The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Interplay of Efflux System, ampC , and oprD Expression in Carbapenem Resistance of Pseudomonas aeruginosa Clinical Isolates
Abstract
Carbapenems are important agents for the therapy of infections due to multidrug-resistant Pseudomonas aeruginosa ; the development of carbapenem resistance hampers effective therapeutic options. To assess the mechanisms leading to resistance, 33 clinical isolates with differing degrees of carbapenem susceptibility were analyzed for the expression of the chromosomal β-lactamase ( ampC ), the porin that is important for the entry of carbapenems ( oprD ), and the proteins involved in four efflux systems ( mexA , mexC , mexE , and mexX ). Real-time reverse transcriptase PCR was performed using primers and fluorescent probes for each of the target genes. The sequencing of regulatory genes ( ampR , mexR , nalC , nalD , mexT , and mexZ ) was also performed. Diminished expression of oprD was present in all imipenem- and meropenem-resistant isolates but was not required for ertapenem resistance. Increased expression of ampC was not observed in several isolates that were overtly resistant to carbapenems. Increased expression of several efflux systems was observed in many of the carbapenem-resistant isolates. Increased efflux activity correlated with high-level ertapenem resistance and reduced susceptibility to meropenem and aztreonam. Most isolates with increased expression of mexA had mutations affecting nalC and/or nalD . Two isolates with mutations leading to a premature stop codon in mexZ had markedly elevated mexX expressions, although mutations in mexZ were not a prerequisite for overexpression. β-Lactam resistance in clinical isolates of P. aeruginosa is a result of the interplay between diminished production of oprD , increased activity of ampC , and several efflux systems.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically
Ferraro, M. J. (2000) · Cited by 16,875
National Committee for Clinical Laboratory Standards
Bruck, E. (1980) · Pediatrics · doi:10.1542/peds.65.1.187 · Cited by 14,751
Multiple Mechanisms of Antimicrobial Resistance in Pseudomonas aeruginosa: Our Worst Nightmare?
Livermore, D. M. (2002) · Clinical Infectious Diseases · doi:10.1086/338782 · Cited by 1,453
Masuda, N., Sakagawa, E., Ohya, S., Gotoh, N., Tsujimoto, H., & Nishino, T. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.12.3322-3327.2000 · Cited by 722
Emerging carbapenemases in Gram-negative aerobes
Nordmann, P., & Poirel, L. (2002) · Clinical Microbiology and Infection · doi:10.1046/j.1469-0691.2002.00401.x · Cited by 684
Ko¨hler, T., Michéa‐Hamzehpour, M., Henze, U., Gotoh, N., Kocjancic Curty, L., & Pechère, J. (1997) · Molecular Microbiology · doi:10.1046/j.1365-2958.1997.2281594.x · Cited by 549
Poole, K., Gotoh, N., Tsujimoto, H., Zhao, Q., Wada, A., Yamasaki, T., Neshat, S., Yamagishi, J., Li, X., & Nishino, T. (1996) · Molecular Microbiology · doi:10.1046/j.1365-2958.1996.281397.x · Cited by 443
Paterson, D. L., Hujer, K. M., Hujer, A. M., Yeiser, B., Bonomo, M. D., Rice, L. B., Bonomo, R. A., & the International Klebsiella Study Group (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.11.3554-3560.2003 · Cited by 394
Of Pseudomonas, porins, pumps and carbapenems
Livermore, D. M. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/47.3.247 · Cited by 391
Aires, J. R., Köhler, T., Nikaido, H., & Plésiat, P. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.11.2624 · Cited by 391
Savli, H., Karadenizli, A., Kolayli, F., Gundes, S., Ozbek, U., & Vahaboglu, H. (2003) · Journal of Medical Microbiology · doi:10.1099/jmm.0.05132-0 · Cited by 331
Poole, K., Tetro, K., Zhao, Q., Neshat, S., Heinrichs, D. E., & Bianco, N. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.9.2021 · Cited by 324
Köhler, T., Epp, S. F., Curty, L. K., & Pechère, J.-C. (1999) · Journal of Bacteriology · doi:10.1128/jb.181.20.6300-6305.1999 · Cited by 302
Landman, D., Quale, J. M., Mayorga, D., Adedeji, A., Vangala, K., Ravishankar, J., Flores, C., & Brooks, S. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.13.1515 · Cited by 301
Self-citationLivermore, D. M. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.9.2046 · Cited by 288
Contribution of the MexX-MexY-OprM Efflux System to Intrinsic Resistance in Pseudomonas aeruginosa
Masuda, N., Sakagawa, E., Ohya, S., Gotoh, N., Tsujimoto, H., & Nishino, T. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.9.2242-2246.2000 · Cited by 279
Li, X. Z., Ma, D., Livermore, D. M., & Nikaido, H. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.8.1742 · Cited by 278
Llanes, C., Hocquet, D., Vogne, C., Benali-Baitich, D., Neuwirth, C., & Plésiat, P. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.5.1797-1802.2004 · Cited by 277
Ziha-Zarifi, I., Llanes, C., Köhler, T., Pechere, J.-C., & Plesiat, P. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.2.287 · Cited by 276
Expression in Escherichia coli of a New Multidrug Efflux Pump, MexXY, from Pseudomonas aeruginosa
Mine, T., Morita, Y., Kataoka, A., Mizushima, T., & Tsuchiya, T. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.2.415 · Cited by 274
Köhler, T., Michea-Hamzehpour, M., Epp, S. F., & Pechere, J.-C. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.2.424 · Cited by 268
Ochs, M. M., McCusker, M. P., Bains, M., & Hancock, R. E. W. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.5.1085 · Cited by 214
Carbapenem Resistance Mechanisms in Pseudomonas aeruginosa Clinical Isolates
Pai, H., Kim, J.-W., Kim, J., Lee, J. H., Choe, K. W., & Gotoh, N. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.2.480-484.2001 · Cited by 205
Maseda, H., Sawada, I., Saito, K., Uchiyama, H., Nakae, T., & Nomura, N. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.4.1320-1328.2004 · Cited by 192
Sobel, M. L., McKay, G. A., & Poole, K. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.10.3202-3207.2003 · Cited by 179
Sobel, M. L., Neshat, S., & Poole, K. (2005) · Journal of Bacteriology · doi:10.1128/jb.187.4.1246-1253.2005 · Cited by 176
Juan, C., Maciá, M. D., Gutiérrez, O., Vidal, C., Pérez, J. L., & Oliver, A. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.11.4733-4738.2005 · Cited by 175
Jeannot, K., Sobel, M. L., El Garch, F., Poole, K., & Plésiat, P. (2005) · Journal of Bacteriology · doi:10.1128/jb.187.15.5341-5346.2005 · Cited by 165
Srikumar, R., Paul, C. J., & Poole, K. (2000) · Journal of Bacteriology · doi:10.1128/jb.182.5.1410-1414.2000 · Cited by 160
Cao, L., Srikumar, R., & Poole, K. (2004) · Molecular Microbiology · doi:10.1111/j.1365-2958.2004.04210.x · Cited by 159
Evans, K., Adewoye, L. O., & Poole, K. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.3.807-812.2001 · Cited by 152
Maseda, H., Saito, K., Nakajima, A., & Nakae, T. (2000) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2000.tb09367.x · Cited by 142
Vogne, C., Aires, J., Bailly, C., Hocquet, D., & Plésiat, P. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.5.1676-1680.2004 · Cited by 141
Maseda, H., Hiroshi Yoneyama, C., & Nakae, T. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.3.658-664.2000 · Cited by 139
Lodge, J., Minchin, S., Piddock, L. J. V., & Busby, S. J. W. (1990) · Biochemical Journal · doi:10.1042/bj2720627 · Cited by 138
Sobel, M. L., Hocquet, D., Cao, L., Plésiat, P., & Poole, K. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.5.1782-1786.2005 · Cited by 138
A large outbreak of multiresistant Pseudomonas aeruginosa strains in north-eastern Germany
Panzig, B. (1999) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/43.3.415 · Cited by 129
Analysis of the Pseudomonas aeruginosa oprD gene from clinical and environmental isolates
Pirnay, J., Vos, D. D., Mossialos, D., Vanderkelen, A., Cornélis, P., & Zizi, M. (2002) · Environmental Microbiology · doi:10.1046/j.1462-2920.2002.00281.x · Cited by 122
Bagge, N., Ciofu, O., Hentzer, M., et al. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.11.3406-3411.2002 · Cited by 121
Adewoye, L. O., Sutherland, A. M., Srikumar, R., et al. (2002) · Journal of Bacteriology · doi:10.1128/jb.184.15.4308-4312.2002 · Cited by 101
Saito, K., Hiroshi Yoneyama, C., & Nakae, T. (1999) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1999.tb08709.x · Cited by 90
Genetic and Phenotypic Variations of a ResistantPseudomonas aeruginosaEpidemic Clone
Hocquet, D., Bertrand, X., Köhler, T., Talon, D. R., & Plésiat, P. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.6.1887-1894.2003 · Cited by 85
Selectivity of ertapenem for Pseudomonas aeruginosa mutants cross-resistant to other carbapenems
Livermore, D. M., Mushtaq, S., & Warner, M. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki009 · Cited by 80
The Role ofmex-Gene Products in Antibiotic Extrusion inPseudomonas aeruginosa
Hiroshi Yoneyama, C., Ocaktan, A., Tsuda, M., & Nakae, T. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6506 · Cited by 74
Wolter, D. J., Moland, E. S., Goering, R. V., Hanson, N. D., & Lister, P. (2004) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2004.05.004 · Cited by 70
Yoneda, K., Chikumi, H., Murata, T., Gotoh, N., Yamamoto, H., Fujiwara, H., Nishino, T., & Shimizu, E. (2004) · FEMS Microbiology Letters · doi:10.1016/j.femsle.2004.11.048 · Cited by 65
The MexA-MexB-OprM multidrug efflux system ofPseudomonas aeruginosais growth-phase regulated
Evans, K., & Poole, K. (1999) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1999.tb13481.x · Cited by 50
Sawada, I., Maseda, H., Nakae, T., Uchiyama, H., & Nomura, N. (2004) · Microbiology and Immunology · doi:10.1111/j.1348-0421.2004.tb03533.x · Cited by 38
Kolaylı, F., Karadenizli, A., Savlı, H., et al. (2004) · Journal of Medical Microbiology · doi:10.1099/jmm.0.45692-0 · Cited by 32
Cited by
Carbapenemases: the Versatile β-Lactamases
Queenan, A. M., & Bush, K. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00001-07 · Cited by 2,499
Updated Functional Classification of β-Lactamases
Bush, K., & Jacoby, G. A. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01009-09 · Cited by 2,367
“tance to carbapenems, especially ertapenem (11, 28, 51).”
BackgroundJacoby, G. A. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00036-08 · Cited by 2,165
The Challenge of Efflux-Mediated Antibiotic Resistance in Gram-Negative Bacteria
Li, X.-Z., Plésiat, P., & Nikaido, H. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00117-14 · Cited by 1,614
Pseudomonas aeruginosa Lifestyle: A Paradigm for Adaptation, Survival, and Persistence
Moradali, M. F., Ghods, S., & Rehm, B. H. A. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00039 · Cited by 1,537
Metadata
- Authors
- Quale, J., Bratu, S., Gupta, J., & Landman, D.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2006-05
- Volume
- 50
- Issue
- 5
- Pages
- 1633-1641
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2142113765
- Cited by
- 409
- References
- 49
- FWCI
- 8.63
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.